Le Lézard
Classified in: Health, Business
Subject: BOARD OF DIRECTORS

Premier Health Announces Hiring of Chief Financial Officer


MONTREAL, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the "Corporation" or "Premier Health"), a leading Canadian Healthtech company, announces the appointment of Guy Daoust as the Corporation's new Chief Financial Officer, effective immediately.

"It is with great pleasure that we welcome Guy to our team. He will make a great addition to the senior leadership team as we continue executing on our growth strategy," said Martin Legault, Chief Executive Officer. "Guy's wide experience will benefit Premier Health and its shareholders at many levels." he added.

Guy Daoust has been part of the management team of a publicly traded Canadian company for more than 15 years. Over that period, he held leadership positions in financing, investments, treasury, accounting, and risk management. He led debt and equity issuances totaling nearly $7 billion and played key roles in supporting that company's sustained growth in Canada and abroad. Guy is a member of the Ordre des comptables professionnels agrées du Québec (CPA).

Interim Chief Financial Officer Simon Belval who joined Premier Health in September 2022 will continue with the Corporation for a transition period.

"Simon made a significant contribution to our organisation. Thanks to his strong capacity to adapt and problem-solving skills, he performed a smooth and efficient transition, including the roll-out of our ERP system." said Martin Legault.

About Premier Health

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper, and more accessible care services.

For Further Information Please Contact:

Mr. Jean-Robert Pronovost

Vice-President, Corporate Development

Premier Health of America Inc.

[email protected] / 1 800 231 9916

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com



These press releases may also interest you

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

at 16:42
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...

at 16:27
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....

at 16:10
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...



News published on and distributed by: